Multiple myeloma and bisphosphonate-related osteonecrosis of the mandible associated with dental implants
- PMID: 22567443
- PMCID: PMC3335612
- DOI: 10.1155/2011/568246
Multiple myeloma and bisphosphonate-related osteonecrosis of the mandible associated with dental implants
Abstract
Multiple myeloma (MM) is a malignant plasma cell disorder and more than 30% of patients with this pathology develop osteolytic lesions in the jaw. Either pamidronate or zoledronic acid is recommended in patients with MM who have one or more lytic lesions. However, bisphosphonate-related osteonecrosis of the jaws (BRONJ) has been described as a complication associated with their use. Otherwise, the use of endosseous implants in oral rehabilitation is a well-established procedure, with good long-term success although systemic factors may affect the bone healing around dental implants. We report the first case reported of MM adjacent to a mandibular dental implant in a patient who developed BRONJ in the same area after intravenous zoledronate treatment. We discuss possible pathogeny of this particular and interesting phenomena.
Figures





References
-
- Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proceedings. 2003;78(1):21–33. - PubMed
-
- Segundo AV-L, Falcão MFL, Correia-Lins Filho R, Soares MSM, López J, Küstner EC. Multiple Myeloma with primary manifestation in the mandible: a case report. Medicina Oral, Patologia Oral y Cirugia Bucal. 2008;13(4):232–234. - PubMed
-
- Roodman GD. Skeletal imaging and management of bone disease. Hematology/The Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2008:313–319. - PubMed
-
- Nowjack-Raymer RE, Sheiham A. Association of edentulism and diet and nutrition in US adults. Journal of Dental Research. 2003;82(2):123–126. - PubMed
Publication types
LinkOut - more resources
Full Text Sources